Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Credit Suisse Downgrades AZEK Co to Neutral

Credit Suisse Downgrades AZEK Co to Neutral

Credit Suisse analyst Daniel Oppenheim downgrades AZEK Co (NYSE:AZEK) from Outperform to Neutral.

byBenzinga Newsdesk

October 14, 2022

1 minute read

Credit Suisse analyst Daniel Oppenheim downgrades AZEK Co (NYSE:AZEK) from Outperform to Neutral.

Amazon Accidentally Leaks Pixel Tablet Specs, Release Date And Price — Google Stays Mum

By Ananya Gairola

May 8, 4:14 AM

Alphabet Inc.’s (NASDAQ:AMZN), giving consumers a glimpse of what to expect from the tech giant’s latest offering. What Happened: During…

AMZN

Molecular Partners Presents Interim Safety And Mechanistic Data From Ongoing Phase 1 Trial Of MP0317 For Treatment of Solid Tumors

By Benzinga Newsdesk

November 10, 2:40 AM

First clinical observation of tumor localized CD40 activation provided by MP0317 No systemic or dose-limiting toxicities observed, a key parameter for CD40 agents Dose escalation remains ongoing with study

MOLN

Global
News

Nubank Reaches The Milestone Of 80M Customers In Latin America

By Happy Mohamed

April 25, 9:51 AM

In the Brazilian market, Nubank ended the first quarter with more than 9 million investor customers and a 36% increase in AuC in one year, totaling R$ 47.6 billion (US$ 9.6 billion) Nubank, one of

Analyst Ratings

EF Hutton Maintains Buy Rating for Limbach Holdings: Here’s What You Need To Know

By Benzinga Insights

May 10, 1:00 PM

EF Hutton has decided to maintain its Buy rating of Limbach Holdings (NASDAQ:LMB) and raise its price target…

LMB

Credit Suisse Downgrades AZEK Co to Neutral

Related Posts

Amazon Accidentally Leaks Pixel Tablet Specs, Release Date And Price — Google Stays Mum

Molecular Partners Presents Interim Safety And Mechanistic Data From Ongoing Phase 1 Trial Of MP0317 For Treatment of Solid Tumors

Nubank Reaches The Milestone Of 80M Customers In Latin America

EF Hutton Maintains Buy Rating for Limbach Holdings: Here’s What You Need To Know